Eutylone

Eutylone is a stimulant and empathogenic drug of the phenethylamine, amphetamine, phenylisobutylamine, and cathinone families which was developed in the 1960s, which is classified as a designer drug. It was first reported to the EMCDDA in 2014 and became widespread internationally in 2019-2020 following bans on the related compound ephylone. It is a synthetic cathinone. In 2021, eutylone was the most common cathinone identified by the Drug Enforcement Administration in the United States.

Pharmacology

Legal status

Sweden's public health agency suggested classifying eutylone as a hazardous substance, on September 25, 2019.
In the United States Eutylone is considered a schedule 1 controlled substance as a positional isomer of Pentylone.